Numerion Labs

Numerion Labs (formerly Atomwise) is an AI-native drug discovery company that pioneered the use of deep learning for structure-based drug design. Its AI chemistry superplatform - built on the COSMOS foundation model, the APEX hyper-scalable enumerator, and EXPO optimization algorithms - explores billions of drug-like molecules to find and optimize novel chemical matter. Based in San Francisco with a San Diego presence, the company is advancing its own pipeline of small-molecule programs in immune and inflammatory disease while collaborating with partners across the pharmaceutical industry.